In the realm of biomanufacturing, the potential impact of mycoplasma contamination events on Chinese hamster ovary (CHO) cell bioreactor cultures is a critical focal point. Mycoplasma, part of the Mollicutes genus, present unique challenges due to their small size and elusive nature. These bacteria, lacking a cell wall, can easily infiltrate sterilizing-grade filters and contaminate bioprocessing schemes via raw materials or manual manipulation steps like cell banking. While mycoplasma may not exhibit overt changes in cell culture performance, their presence can subtly alter culture dynamics, affecting nutrient competition, cell growth, and product quality. Detecting and removing mycoplasma is crucial to prevent production loss and costly cleanups, especially in the biopharmaceutical industry where patient safety is paramount.
Despite the potential risks mycoplasma pose, there remains a dearth of literature on the kinetics and process impacts of intentional mycoplasma contamination in commercial upstream biomanufacturing. Typically, firms swiftly decontaminate upon discovering mycoplasma, limiting the study of contamination effects. Past studies have focused on mycoplasma contaminating cell lines in standard vessels, lacking insights into bioreactor cultures where real-time monitoring and control of process parameters are feasible. Bioreactors, with their ability to mimic commercial operations closely, provide a more representative model for studying mycoplasma contamination effects in upstream processes. By delving into the intricacies of mycoplasma interactions within CHO cell bioreactors, researchers can illuminate the subtle yet significant impacts on culture performance and product quality.
Efforts to enhance mycoplasma detection methods have led to the exploration of nucleic acid testing (NAT) to enable rapid identification. However, challenges in method validation hinder widespread adoption. To bridge this gap, studies have been conducted to simulate contamination events using Mycoplasma arginini and CHO cells expressing a model monoclonal antibody. These studies delve into the growth kinetics of M. arginini in controlled bioreactor environments and its repercussions on CHO cell culture performance and process parameters. By closely monitoring key indicators like dissolved oxygen, pH, nutrient consumption, and waste production, researchers aim to identify early signs of mycoplasma contamination before traditional methods yield results.
In seed train expansion and inoculum preparation, a recombinant CHO DG44 cell line expressing a model antibody was cultured in spinner flasks before inoculation into single-use bioreactors. The study meticulously tracked M. arginini growth, CHO cell viability, and nutrient dynamics post-contamination. Notably, mycoplasma spiking led to distinct changes in CHO cell growth profiles, viability, and nutrient consumption, shedding light on the intricate interplay between mycoplasma and CHO cells. The data revealed that mycoplasma contamination significantly influenced CHO cell health, metabolism, and productivity, underscoring the need for vigilant monitoring and early intervention strategies.
To assess the impact of mycoplasma contamination on culture conditions and process controls, researchers closely monitored pH and dissolved oxygen levels post-contamination. These critical parameters serve as potential sentinels for contamination, with deviations indicating mycoplasma presence and its effects on culture dynamics. By studying CHO cell IgG1 production post-contamination, researchers gained insights into productivity changes, highlighting how mycoplasma contamination can disrupt antibody production rates. Despite fluctuations in CHO cell density and viability post-contamination, CHO cells exhibited varying degrees of productivity, underscoring the complex and dynamic nature of mycoplasma-CHO cell interactions.
The study’s meticulous approach to exploring the impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures unveils a nuanced narrative of microbial intrusion and its ramifications on biomanufacturing processes. By deciphering the subtle cues and alterations induced by mycoplasma, researchers are paving the way for more robust detection methods and proactive mitigation strategies in the biopharmaceutical industry. This in-depth analysis not only enhances our understanding of mycoplasma contamination effects but also underscores the importance of real-time monitoring and process control in safeguarding bioprocessing integrity.
Key Takeaways:
- Mycoplasma contamination poses significant risks to biomanufacturing processes, necessitating vigilant detection and mitigation strategies.
- Bioreactors serve as valuable models for studying mycoplasma contamination effects in commercial upstream operations due to their process control capabilities.
- Monitoring key parameters like dissolved oxygen, pH, and nutrient dynamics can offer early indications of mycoplasma contamination in CHO cell bioreactor cultures.
- The intricate interplay between mycoplasma and CHO cells influences cell health, metabolism, and productivity, impacting antibody production rates.
- By unraveling the complex implications of mycoplasma contamination, researchers are advancing our knowledge of microbial interactions in biomanufacturing settings.
Tags: bioreactor, cell banking, upstream, cell culture, chromatography, downstream
Read more on pmc.ncbi.nlm.nih.gov
